Maculopathy is any disease or damage affecting the macula, the small area at the center of your retina responsible for sharp, detailed vision. The macula is only about 5.5 millimeters across, but it handles nearly everything you rely on for reading, recognizing faces, driving, and seeing color. When it’s damaged, central vision deteriorates while peripheral (side) vision usually remains intact.
What the Macula Does
The retina lines the back of your eye like wallpaper, converting light into signals your brain interprets as images. The macula sits right at the center of that surface and contains the highest concentration of cone photoreceptors, the cells that detect fine detail and color. At the very center of the macula is a tiny pit called the fovea, roughly 1.5 millimeters wide, packed almost exclusively with cones. This is the spot your eye aims at whatever you’re looking at directly.
Because so much of your detailed vision depends on this one small region, even minor damage there can have outsized effects on daily life. Conditions that cause swelling, fluid buildup, or tissue loss in the macula all fall under the umbrella term “maculopathy.”
Common Types of Maculopathy
Several distinct conditions can damage the macula. The most widely recognized include:
- Age-related macular degeneration (AMD): The most common cause of severe vision loss in older adults. It comes in a “dry” form, where the macula gradually thins, and a “wet” form, where abnormal blood vessels leak fluid beneath the retina. Globally, the number of people with vision impairment from AMD more than doubled between 1990 and 2021, rising from about 3.6 million to over 8 million.
- Diabetic maculopathy: A complication of diabetes in which high blood sugar damages the tiny blood vessels feeding the macula. It can be focal (leakage from specific spots, often surrounded by rings of fatty deposits), diffuse (a widespread breakdown of the blood vessel barrier causing general swelling), or ischemic (blood vessels close off entirely, starving the macula of oxygen). The ischemic form is the most difficult to treat.
- Drug-induced maculopathy: Certain medications can be toxic to the macula over time. Hydroxychloroquine, commonly prescribed for lupus and rheumatoid arthritis, is the best-known culprit and can produce a characteristic “bull’s eye” pattern of damage.
- Epiretinal membrane: A thin sheet of scar tissue forms on the macula’s surface, wrinkling it and distorting vision.
- Macular hole: A small break develops in the fovea, causing a blind spot right in the center of vision.
- Central serous retinopathy: Fluid collects under the macula, often in younger adults under stress, causing a bubble-like detachment that blurs and distorts central vision.
Symptoms to Recognize
The hallmark of maculopathy is a change in your central vision while your side vision stays normal. The most common symptoms are blurred central vision, difficulty reading or recognizing faces, and metamorphopsia, which is a distortion of shapes. Straight lines may appear wavy or bent, and people often describe the effect as “wave-like.” Some people develop a scotoma, a dark or blank patch in the center of their visual field.
These symptoms can develop gradually (as in dry AMD) or appear suddenly (as in wet AMD or central serous retinopathy). Metamorphopsia sometimes goes unnoticed during normal activity because the brain compensates, which is one reason regular screening matters for people at higher risk. A simple grid of straight lines, called an Amsler grid, is a common at-home tool for detecting new distortion, though it has limits in sensitivity.
Risk Factors
Age is the strongest non-modifiable risk factor. Genetics also plays a major role: having a sibling with AMD increases your own risk roughly 12-fold, and that risk climbs even higher if a parent is affected.
Among modifiable risk factors, smoking stands out. Tobacco releases substances that generate free radicals, which concentrate in the retina and accelerate damage. Obesity increases the risk of developing AMD by about 32%, based on pooled data from seven large studies. High blood pressure, cardiovascular disease, and diabetes are all linked to higher risk as well. A diet heavy in foods that spike blood sugar quickly has been associated with both the development and progression of macular degeneration.
On the protective side, strong adherence to a Mediterranean-style diet, rich in leafy greens, colorful fruits and vegetables, whole grains, nuts, and fish, is associated with a lower risk of late-stage AMD. Regular physical activity also appears protective, while prolonged sunlight exposure may modestly increase risk. One large study found that people who spent more time outdoors had more than twice the odds of developing early AMD.
How Maculopathy Is Diagnosed
Optical coherence tomography (OCT) has become the cornerstone of macular diagnosis. It works like an ultrasound but uses light instead of sound, producing detailed cross-sectional images of the retina in seconds. The scan is painless and noninvasive. It can measure retinal thickness down to the micrometer, map swelling or thinning across the macula, and track changes between visits with color-coded comparison maps. The central one-millimeter thickness measurement correlates closely with visual acuity, making it a reliable way to monitor how the disease is affecting function.
Fluorescein angiography is another key tool, particularly for diabetic maculopathy. A dye is injected into a vein in your arm and photographed as it flows through the retinal blood vessels, revealing areas of leakage or poor blood flow. In central serous retinopathy, angiography shows a characteristic point of leakage that matches the fluid pocket seen on OCT. For hydroxychloroquine screening, the American Academy of Ophthalmology recommends OCT along with a wide pattern of autofluorescence imaging as primary tools, with visual field testing and electrical response testing of the retina as supplementary checks.
Treatment Approaches
Treatment depends entirely on the type of maculopathy.
For wet AMD, the standard treatment involves injections directly into the eye that block a protein responsible for abnormal blood vessel growth and leakage. These injections reduce swelling, slow vessel growth, and can improve vision. The catch is that they typically need to be repeated, often monthly at first, then at longer intervals as the condition stabilizes. Clinical studies have shown significant improvements in visual acuity and reductions in macular swelling within months of starting treatment.
Diabetic maculopathy with swelling is treated similarly, with eye injections and sometimes laser therapy. Focal diabetic maculopathy responds well to targeted laser treatment aimed at the specific leaking spots. Diffuse swelling is harder to manage and may require a combination of injections and laser. Ischemic diabetic maculopathy, where the blood supply has been cut off, currently has no effective treatment.
Drug-induced maculopathy from hydroxychloroquine is managed primarily through prevention and early detection. The recommended dosage stays at or below 5 mg per kilogram of body weight. A baseline eye exam including OCT is strongly advised soon after starting the medication, and annual screening is recommended. Screening can be deferred for the first five years if no significant risk factors are present, but should begin immediately if risk factors exist. If early toxicity is caught, stopping the drug can prevent further damage, though existing damage is generally permanent.
For epiretinal membranes and macular holes, surgery is the primary option. In studies of surgical repair, 70% of patients gained meaningful vision improvement (two or more lines on an eye chart), compared to only 10% of those who were simply observed. Nine out of ten surgically treated patients achieved functional reading vision afterward.
Dry AMD currently has no cure, but nutritional supplements containing specific antioxidant and mineral combinations can slow progression in intermediate cases. Lifestyle modifications, particularly quitting smoking, maintaining a healthy weight, and eating a nutrient-rich diet, remain the most important steps for anyone with early macular changes.
Hydroxychloroquine Screening Timeline
Because hydroxychloroquine toxicity is both preventable and irreversible, the screening schedule deserves specific attention. You should have a full baseline exam, including OCT and autofluorescence imaging, soon after starting the medication. If you have no additional risk factors (such as kidney disease or higher dosing), annual screening can be deferred until year five. After that, or from the start if risk factors are present, yearly screening is essential. The goal is to catch the earliest signs of retinal thinning before you notice any vision changes, because by the time symptoms appear, significant damage has already occurred.
Living With Maculopathy
Maculopathy does not cause total blindness. Even in advanced cases, peripheral vision is preserved, which means you can still navigate spaces and maintain independence. The central vision loss, however, affects the tasks most people value most: reading, watching screens, cooking, and driving. Low-vision aids such as magnifiers, large-print devices, and screen readers can make a substantial difference. Many people adapt well, particularly when the condition is caught early and managed actively.